BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Obelis Group - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Obelis Group
X-ORIGINAL-URL:https://www.obelis.net
X-WR-CALDESC:Events for Obelis Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260121T000000
DTEND;TZID=Europe/Brussels:20260331T235959
DTSTAMP:20260418T031331
CREATED:20260119T120409Z
LAST-MODIFIED:20260121T084922Z
UID:10000031-1768953600-1775001599@www.obelis.net
SUMMARY:Benzophenone‑3 & Methyl Salicylate Restrictions  – January and March 2026
DESCRIPTION:United Kingdom – Benzophenone‑3 & Methyl Salicylate Restrictions Deadlines\n\n\n\n✅21 January 2026: Cosmetic products containing Benzophenone-3 and not complying with the restrictions outlined in Annex VI can no longer be placed on Great Britain’s market. For full details on the restrictions\, please refer to this link. \n\n\n\n✅31 March 2026: Cosmetic products containing Methyl Salicylate (CAS 119-36-8)and not complying with the restrictions outlined in Annex III can no longer be made available on Great Britain’s market. For full details on the restrictions\, please refer to this link. \n\n\n\nCheck your product portfolio now to ensure compliance with the upcoming UK cosmetic ingredient restrictions and avoid market disruptions. Appoint Obelis now to manage your compliance.
URL:https://www.obelis.net/events/benzophenone%e2%80%913-methyl-salicylate-restrictions-january-and-march-2026/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/281.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260312T150000
DTEND;TZID=Europe/Brussels:20260312T160000
DTSTAMP:20260418T031331
CREATED:20260302T111932Z
LAST-MODIFIED:20260306T100841Z
UID:10000039-1773327600-1773331200@www.obelis.net
SUMMARY:Powering Compliance: EU Battery Regulation for Portable Batteries
DESCRIPTION:Join us for an insightful webinar on EU battery regulation\, with a focus on portable batteries. We will cover an overview of the EU Battery Regulation\, highlight the main novelties\, and explore key provisions specific to portable batteries. Gain practical guidance\, understand compliance requirements\, and learn how to navigate the evolving regulatory landscape effectively.🎯 When: March 12 | 15:00-16:00 CET \n\n\n\n📌 Where: Online | Zoho Webinars  \n\n\n\n🎬 Guests: Simona Varrella (Obelis Group | Senior RII International Specialist – Regulatory Intelligence & Innovation) and Pablo Antiñanco (Director at RoHS or not)
URL:https://www.obelis.net/events/powering-compliance-eu-battery-regulation-for-portable-batteries-webinar/
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/03/Event-Calendar-Featured-Image-28.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260326T090000
DTEND;TZID=Europe/Brussels:20260328T180000
DTSTAMP:20260418T031331
CREATED:20260107T145612Z
LAST-MODIFIED:20260108T083727Z
UID:10000027-1774515600-1774720800@www.obelis.net
SUMMARY:Cosmoprof Bologna
DESCRIPTION:Heading to Cosmoprof Bologna?One of the leading global events for the beauty and cosmetics industry\, Cosmoprof Bologna is a key platform for international growth and Obelis Group is pleased to be part of it. \n\n\n\nAt Obelis\, we support companies in navigating complex cosmetics regulatory landscapes\, enabling confident and efficient access to global markets. \n\n\n\nWhat you can expect when you meet us at Cosmoprof Bologna: \n\n\n\n✅ Strategic advice on expanding into international markets✅ Clear guidance on regulatory and compliance requirements for your product category✅ Practical support to streamline approvals and reduce time to market \n\n\n\nLet’s plan ahead. Book a slot with our experts and make the most of your visit.  \n\n\n\nLooking forward to connecting with you at Cosmoprof Bologna!
URL:https://www.obelis.net/events/cosmoprof-bologna/
CATEGORIES:Exhibitions
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/Event-Calendar-Featured-Image-19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260326T160000
DTEND;TZID=Europe/Brussels:20260326T170000
DTSTAMP:20260418T031331
CREATED:20260317T080848Z
LAST-MODIFIED:20260323T131642Z
UID:10000042-1774540800-1774544400@www.obelis.net
SUMMARY:Navigating U.S. FDA Medical Device Regulations: Pathways & Lifecycle Compliance
DESCRIPTION:Entering the U.S. medical device market requires a clear understanding of FDA regulatory requirements throughout the entire product lifecycle. This webinar will guide you through the key elements manufacturers must consider when placing a device on the U.S. market and maintaining compliance over time.Our experts will cover essential topics including:✅Device classification✅Regulatory pathways (510(k)\, De Novo\, and PMA)✅Labelling requirements✅Post-market surveillance obligations✅UDI implementation✅Implications of the FDA’s new Quality Management System Regulation (QMSR)Join us to gain practical insights into navigating the FDA regulatory framework and ensuring your medical devices remain compliant from market entry through post-market monitoring.
URL:https://www.obelis.net/events/fda-medical-device-regulations-us-market-pathways-lifecycle-compliance/
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/03/US-Labeling-Webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260412T000000
DTEND;TZID=Europe/Brussels:20260412T235959
DTSTAMP:20260418T031331
CREATED:20260119T135238Z
LAST-MODIFIED:20260121T085012Z
UID:10000032-1775952000-1776038399@www.obelis.net
SUMMARY:Canada Fragrance Allergen Disclosure – April 2026
DESCRIPTION:Canada – Fragrance Allergen Disclosure Deadline\n\n\n\n✅12 April 2026: New and existing cosmetics have to disclose the 24 fragrance allergens listed below within the list of ingredients\, when present at concentration greater than 0.01% in rinse-off products and 0.001% in leave-on products. \n\n\n\nTo ensure compliance with the above regulatory changes\, we recommend reviewing and\, where necessary\, revising your product formulations. Obelis is here to support you at every step of the process.
URL:https://www.obelis.net/events/canada-fragrance-allergen-disclosure-april-2026/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/291.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260414T090000
DTEND;TZID=Europe/Brussels:20260417T180000
DTSTAMP:20260418T031331
CREATED:20260224T150728Z
LAST-MODIFIED:20260311T143637Z
UID:10000038-1776157200-1776448800@www.obelis.net
SUMMARY:Interclean Amsterdam
DESCRIPTION:Making plans to attend Interclean Amsterdam? \n\n\n\nThis April\, the world’s leading cleaning and hygiene event returns to the RAI Amsterdam with an expanded show floor and more international exhibitors. Interclean Amsterdam is the premier stage for the professional cleaning industry and Obelis Group is proud to be part of the movement. \n\n\n\nAt Obelis\, we help manufacturers of detergents\, disinfectants and professional cleaning equipment navigate the rigorous EU and global regulatory landscapes. Whether you are launching a new biocidal product or scaling smart cleaning technology\, we ensure your path to market is compliant\, confident\, and efficient. \n\n\n\nWhat you can expect when you meet us at Interclean: \n\n\n\n✅ Expert Regulatory Guidance: Deep dives into compliance for detergents\, disinfectants and Personal Protective Equipment (PPE).✅ Strategic Market Access: Advice on navigating the EU and UK markets\, including Responsible Person and Authorized Representative services.✅ Innovation Support: Practical insights on streamlining approvals for the latest tech showcased in the Robot and Healthcare Experience Centers. \n\n\n\nWith the industry shifting toward automation and sustainability\, having a strong regulatory strategy is more important than ever. Book a slot with our experts today to ensure your innovations are ready for the global stage. \n\n\n\nLooking forward to connecting with you in Amsterdam this April!
URL:https://www.obelis.net/events/interclean-amsterdam/
CATEGORIES:Exhibitions
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/02/Interclean.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260416T150000
DTEND;TZID=Europe/Brussels:20260416T160000
DTSTAMP:20260418T031331
CREATED:20260331T073455Z
LAST-MODIFIED:20260331T073459Z
UID:10000044-1776351600-1776355200@www.obelis.net
SUMMARY:The Critical Role of the Responsible Technical Person
DESCRIPTION:2026 is a critical year for cosmetic compliance – and the Responsible Technical Person is at the center of it.Join our 60-minute LIVE webinar to discover how to safeguard your products\, avoid regulatory risks\, and implement GMP with ISO 22716. ✅ GMP Essentials: key principles for cosmetic products✅ RTP Responsibilities: legal and operational must-knows✅ Practical Tips: ensure compliance efficiently✅ Expert Insights: from Sandra Ferretti\, CCO at Obelis Group\, and Selim Erol\, CEO of Obelis TürkiyeReserve your spot now and stay ahead in cosmetic compliance!
URL:https://www.obelis.net/events/cosmetic-compliance-2026-gmp-iso-22716-rtp-webinar/
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/03/Turkiye-webinar-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260421T160000
DTEND;TZID=Europe/Brussels:20260421T170000
DTSTAMP:20260418T031331
CREATED:20251203T133359Z
LAST-MODIFIED:20260106T112158Z
UID:10000026-1776787200-1776790800@www.obelis.net
SUMMARY:ON-DEMAND WEBINAR: Food Supplements in the EU and UK – a focus on online sales (AMAZON)
DESCRIPTION:Get a clear and practical overview of the essential rules governing food supplements in the EU and UK. This on-demand webinar walks you through the core legislation and compliance requirements every Food Business Operator (FBO) must know.Webinar highlights :✅ Regulation (EC) 178/2002 – General Food Law✅ Brexit and its impact on labeling & notifications✅ Compliance challenges when selling on Amazon✅ How Obelis can support you as your FBOIdeal for manufacturers\, distributors\, Amazon sellers\, and regulatory professionals looking for a quick\, reliable guide to staying compliant in the EU and UK.
URL:https://www.obelis.net/events/on-demand-webinar-food-supplements-in-the-eu-and-uk-a-focus-on-online-sales-amazon/
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2025/12/Event-Calendar-Featured-Image-16.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260501T000000
DTEND;TZID=Europe/Brussels:20260501T235959
DTSTAMP:20260418T031331
CREATED:20260119T105105Z
LAST-MODIFIED:20260121T084723Z
UID:10000030-1777593600-1777679999@www.obelis.net
SUMMARY:Omnibus Act VIII – May 2026
DESCRIPTION:European Union – Omnibus Act VIII amends the Cosmetic Regulations\n\n\n\n✅1 May 2026: Products containing 3-(4′-methylbenzylidene)-camphor [INCI: 4-Methylbenzylidene Camphor] (CAS No 36861-47-9/38102-62-4) can no longer be made available on the market. \n\n\n\n✅1 May 2026: With no distinction between placing products on the market and making them available\, Omnibus Act VIII will apply. This means that\, from the application date\, non-compliant cosmetics can no longer be sold in the EU market and must be recalled beforehand. \n\n\n\nMeeting regulatory deadlines is essential to avoid market disruptions and product recalls\, and Obelis is here to support you every step of the way in ensuring timely compliance with Omnibus Act VIII requirements. \n\n\n\n\n\n\n\n\nNew amendment to EU Cosmetics Regulation: Retinol and other substances banned or restricted in cosmetics – COSlaw.eu – Guiding through EU Cosmetics Regulations: Winning with IVDR: Compliance Strategy\, Class C Pathways & NB Engagement
URL:https://www.obelis.net/events/omnibus-act-viii-may-2026/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/271.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260505T090000
DTEND;TZID=Europe/Brussels:20260506T180000
DTSTAMP:20260418T031331
CREATED:20260311T141728Z
LAST-MODIFIED:20260311T143344Z
UID:10000041-1777971600-1778090400@www.obelis.net
SUMMARY:GITEX Future Health Africa
DESCRIPTION:Heading to GITEX Future Health Africa?As Africa’s leading platform for health innovation and policy\, GITEX Future Health Africa is where healthcare’s evolution meets the continent’s digital future. Obelis Group is more than excited to be a part of this transformative event in Morocco this May. \n\n\n\nIn an era where AI and deep tech are reimagining health systems\, Obelis stands ready to support your journey. We help MedTech and Digital Health innovators navigate complex regulatory landscapes. \n\n\n\nWhat you can expect when you meet us in Morocco: \n\n\n\n✅ Strategic Roadmaps: Expert advice on scaling your health innovations across African and international borders.✅ Tech-Forward Compliance: Clear guidance on regulatory requirements for AI-driven devices\, software as a medical device (SaMD)\, and emerging health tech.✅ Accelerated Market Entry: Practical support to streamline approvals\, ensuring your life-saving technology reaches providers and patients faster. \n\n\n\nDon’t leave your regulatory strategy to chance. Book a dedicated slot with our experts ahead of time and maximise your impact at GITEX Future Health Africa. \n\n\n\nLooking forward to connecting with you in Morocco on 5-6 May!
URL:https://www.obelis.net/events/gitex-future-health-africa/
CATEGORIES:Exhibitions
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/03/GITEX.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260506T113000
DTEND;TZID=Europe/Brussels:20260506T123000
DTSTAMP:20260418T031331
CREATED:20260414T131053Z
LAST-MODIFIED:20260414T131248Z
UID:10000045-1778067000-1778070600@www.obelis.net
SUMMARY:Winning with IVDR: Compliance Strategy\, Class C Pathways & NB Engagement
DESCRIPTION:The IVDR transition is reshaping how IVD manufacturers approach compliance\, evidence\, and certification. This session will guide you through the most critical elements of the journey\, from transition timelines and legacy provisions\, to EUDAMED and UDI requirements\, and what they mean in practice. \n\n\n\nWe will also dive into Class C classification and conformity assessment pathways\, highlight the most common clinical evidence gaps identified by Notified Bodies\, and share practical insights on how to work more effectively with Notified Bodies\, including smarter communication and selection strategies to support successful approvals.Join us to gain clarity\, reduce compliance risks\, and strengthen your IVDR strategy. Register now to secure your spot.
URL:https://www.obelis.net/events/winning-with-ivdr-compliance-strategy-class-c-pathways-nb-engagement/
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/04/Event-Calendar-Featured-Image-29.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260507T100000
DTEND;TZID=Europe/Brussels:20260509T180000
DTSTAMP:20260418T031331
CREATED:20260319T105438Z
LAST-MODIFIED:20260413T141312Z
UID:10000043-1778148000-1778349600@www.obelis.net
SUMMARY:Beauty Istanbul 2026
DESCRIPTION:Keen on Beauty Care? Let’s meet at Beauty Istanbul\, one of the largest cosmetics exhibitions worldwide! Our Mission? Helping cosmetics brands seamlessly adapt to global compliance standards.Why Meet Us at Beauty Istanbul?✅ Expert insights on market access & compliance✅ Tailored strategies to accelerate approvals✅ Guidance on the latest regulatory updatesLet’s connect to discuss how we can support your regulatory needs! Schedule a meeting with us in advance\, and we’ll see you at our booth\, yours\, or wherever is convenient for you. \n\n\n\nObelis Booth: Hall 10/10A 430We look forward to meeting you at Beauty Istanbul!
URL:https://www.obelis.net/events/beauty-istanbul-2026/
CATEGORIES:Exhibitions
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/03/GITEX-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260526T000000
DTEND;TZID=Europe/Brussels:20260526T235959
DTSTAMP:20260418T031331
CREATED:20260127T081634Z
LAST-MODIFIED:20260127T082030Z
UID:10000037-1779753600-1779839999@www.obelis.net
SUMMARY:IVDR Class C Transitional Deadline – May 2026
DESCRIPTION:As the transition to the In Vitro Diagnostic Regulation (IVDR) continues\, we would like to remind you of the critical 2026 deadlines for legacy IVDs that are classified to Class C under IVDR. \n\n\n\nFor these devices\, the following milestones apply:  \n\n\n\n✅A written agreement between the manufacturer and the Notified Body must be signed by 26 September 2026. \n\n\n\n✅The manufacturer or their Authorised Representative must apply to a Notified Body for IVDR conformity assessment by 26 May 2026. \n\n\n\nObelis guides manufacturers through the IVDR transition\, including selecting and engaging with a Notified Body.
URL:https://www.obelis.net/events/ivdr-class-c-transitional-deadline-may-2026/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/331.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260528T000000
DTEND;TZID=Europe/Brussels:20260528T235959
DTSTAMP:20260418T031331
CREATED:20260127T081040Z
LAST-MODIFIED:20260127T081211Z
UID:10000036-1779926400-1780012799@www.obelis.net
SUMMARY:EUDAMED Registration Becomes Mandatory – May 2026
DESCRIPTION:Regulatory Alert | EUDAMED becomes mandatory\n\n\n\nCommission Decision (EU) 2025/2371 confirms the full functionality of the first four EUDAMED modules. As a result\, economic operators must comply with mandatory registration requirements. \n\n\n\nMandatory modules from 28 May 2026: \n\n\n\n✅Market Surveillance \n\n\n\n✅Actors: registration of manufacturers\, authorised representatives\, importers \n\n\n\n✅UDI / Devices: device registration (excluding custom-made devices) \n\n\n\n✅Notified Bodies & Certificates \n\n\n\nA six-month transition period (until November 27\, 2026) applies only to devices placed on the market before May 28\, 2026. Devices placed on the market after this date must be registered before market access. \n\n\n\nObelis supports manufacturers at every step of EUDAMED compliance!
URL:https://www.obelis.net/events/eudamed-registration-becomes-mandatory-may-2026/
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://www.obelis.net/wp-content/uploads/2026/01/341.jpg
END:VEVENT
END:VCALENDAR